FDA releases the second of two draft guidances aimed at supporting the development of novel nicotine replacement therapies.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes